Shelley B. Thunen, EVP & CFO at INTRALASE CORP (ILSE), sold 8,378 shares at $20.37 ($170K) on 2006-03-22, disclosed to the SEC on 2006-03-23.
Scheduled sale ($170k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.22 | 1,878 | $38K | 22.3% |
| 2 | $20.23 | 100 | $2K | 1.2% |
| 3 | $20.24 | 200 | $4K | 2.4% |
| 4 | $20.25 | 300 | $6K | 3.6% |
| 5 | $20.27 | 103 | $2K | 1.2% |
| 6 | $20.28 | 1,217 |
| $25K |
| 14.5% |
| 7 | $20.29 | 500 | $10K | 6.0% |
| 8 | $20.30 | 1,400 | $28K | 16.7% |
| 9 | $20.31 | 300 | $6K | 3.6% |
| 10 | $20.32 | 75 | $2K | 0.9% |
| 11 | $20.33 | 805 | $16K | 9.6% |
| 12 | $20.34 | 1,300 | $26K | 15.6% |
| 13 | $20.37 | 200 | $4K | 2.4% |
| Total | $20.29 avg | 8,378 | $170K | 100% |
| Filing → |
| RXST | SELL | 2024-05-02 | $1.0M | — | Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |